Warfarin: Mechanisms for Durable Effects in Coronary Artery Disease

Publisher： Karger

E-ISSN： 1424-0556|2|4|184-191

ISSN： 1422-9528

Source： Heart Drug, Vol.2, Iss.4, 2002-11, pp. : 184-191

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Celecoxib: beneficial effects in coronary artery disease

By  

Inpharma, Vol. 1, Iss. 1374, 2003-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Nitric oxide in coronary artery disease: effects of antioxidants

By Tousoulis Dimitris   Antoniades Charalambos   Stefanadis Christodoulos  

European Journal of Clinical Pharmacology, Vol. 62, Iss. 1, 2006-02 ,pp. : 101-107

Springer Publishing Company

Access to resources Recommend Favorite

Different Effects of Simvastatin and Losartan on Cytokine Levels in Coronary Artery Disease

By Sadamatsu Kenji  

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 3, 2006-01 ,pp. : 169-175

Adis International

Access to resources Recommend Favorite

Effects of Metabolic Approach in Diabetic Patients with Coronary Artery Disease

By  

Current Pharmaceutical Design, Vol. 15, Iss. 8, 2009-03 ,pp. : 857-862

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of the Coronary Collateral Circulation on the Tp-e Interval and Tp-e/QT Ratio in Patients with Stable Coronary Artery Disease

By  

Annals of Noninvasive Electrocardiology, Vol. 20, Iss. 1, 2015-01 ,pp. : 53-61

Blackwell Publishing

Access to resources Recommend Favorite